← Leaderboards
Jeffrey Ulmer
Novartis Vaccines And Diagnostics, Inc.
$14,945,023
Attributed
$14,945,023
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2006–10$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$14,945,023 · 4
By mechanism
UC1$10,427,728 · 1
P01$4,517,295 · 3
Top collaborators
No co-investigators on record.
Most similar at Novartis Vaccines And Diagnostics, Inc.
Same institution · by research overlap
- Michael S Vajdy$584,179
- Indresh K Srivastava$3,957,471
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseRecombinant ProteinsOryctolagus CuniculusImmunologicsNonhuman PrimateHiv AntibodiesAreaAntigensArtsImmunogenicityNew TechnologyBaseBinding (Molecular Function)Adenovirus VectorBioreactorsAlphavirusCell LineChinese Hamster Ovary CellEvaluationAdjuvantAnimal ModelDatabasesAnimalsNeutralizing Antibody
Grant awards (7)
Vaccine Technologies$1,017,293
P01 · FY2010 · AI · contact PI
Vaccine Technologies$908,875
P01 · FY2009 · AI · contact PI
Vaccine Technologies$902,991
P01 · FY2008 · AI · contact PI
Vaccine Technologies$894,764
P01 · FY2007 · AI · contact PI
Vaccine Technologies$793,372
P01 · FY2006 · AI · contact PI
Development of a SARS Coronavirus Vaccine$10,427,728
UC1 · FY2004 · AI
Core--Vaccine Technologies$0
P01 · FY2002 · AI